You have Guest access.
Log In
Guntram Schernthaner and Gerit Schernthaner
Journal Article
Drug evaluation: Vildagliptin-metformin single-tablet combination
Abd A. Tahrani, Milan K. Piya and Anthony H. Barnett
Advances in Therapy, 2009, Volume 26, Number 2, Pages 138-154
Book Chapter
Type 2 Diabetes Mellitus: An Evidence-Based Approach to Practical Management Noninsulin Pharmacological Therapies
Ildiko Lingvay, Chanhaeng Rhee and Philip Raskin
Contemporary Endocrinology, 2008, Type 2 Diabetes Mellitus, Pages 151-167
Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936
J. A. Tayek
Diabetologia, 2006, Volume 49, Number 11, Pages 2807-2808
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis
G. Schernthaner, A. H. Barnett, D. J. Betteridge, R. Carmena and A. Ceriello, et al.
Diabetologia, 2010, Volume 53, Number 7, Pages 1258-1269
Comment on: Evans JM, Ogston SA, Emslie-Smith A, Morris A (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936
J. A. Johnson, S. H. Simpson, D. T. Eurich and S. R. Majumdar
Diabetologia, 2006, Volume 49, Number 11, Pages 2805-2806
Metformin: Effects on Micro and Macrovascular Complications in Type 2 Diabetes
Clifford J. Bailey
Cardiovascular Drugs and Therapy, 2008, Volume 22, Number 3, Pages 215-224
D. Raccah
Diabetologia, 2007, Volume 50, Number 5, Pages 1109-1110
Are sulfonylureas passé?
Jennifer B. Green and Mark N. Feinglos
Current Diabetes Reports, 2006, Volume 6, Number 5, Pages 373-377
ADOPT: Lessons from Comparison of Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
Hannele Yki-Jarvinen
Current Diabetes Reports, 2007, Volume 7, Number 3, Pages 173-174
Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes
Hamiyet Yilmaz, Alptekin Gursoy, Mustafa Sahin and Nilgun Guvener Demirag
Acta Diabetologica, 2007, Volume 44, Number 4, Pages 187-192
Frequently asked questions General info on journals and books Send us your feedback Impressum Contact us
© Springer, Part of Springer Science+Business Media Privacy, Disclaimer, Terms & Conditions, and Copyright Info